SCHEMBL24675062

SCHEMBL24675062

Cc1cnc2c(n1)CC[C@@H]1CN(C)CCN21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.43
HTR2C P28335 6/20 0.43
HTR2B P41595 6/20 0.43
HCRTR1 O43613 3/20 0.31
HCRTR2 O43614 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CHRM2 P08172 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
CHRM1 P11229 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
ADRA2B P18089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675075 1.00 HTR2A (0.43) HTR2AHTR2CHTR2BHCRTR1HCRTR2
SCHEMBL24675377 0.76 HTR2A (0.42) HTR2AHTR2CHTR2BHCRTR1HCRTR2
SCHEMBL24675070 0.73 MEN1 (0.36) HTR2AHTR2CHTR2BMEN1KMT2A
SCHEMBL24675063 0.73 MEN1 (0.36) HTR2AHTR2CHTR2BMEN1KMT2A
SCHEMBL24675059 0.73 MEN1 (0.36) HTR2AHTR2CHTR2BMEN1KMT2A
SCHEMBL26958160 0.70 HTR2A (0.47) HTR2AHTR2CHTR2BALDH1A1SMN1; SMN2
SCHEMBL24640938 0.68 HTR2A (0.38) HTR2AHTR2CHTR2BCYP2D6CYP2C9
SCHEMBL24640360 0.68 HTR2A (0.38) HTR2AHTR2CHTR2BCYP2D6CYP2C9
SCHEMBL46330 0.68 GRM5 (0.37) ALDH1A1HTR3A
SCHEMBL24675043 0.67 HTR2A (0.37) HTR2AHTR2CHTR2BCYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022223022-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2022-10-27 WO disclosed